Scientists test inhaled TB vaccine to boost protection
NCT ID NCT06246851
Summary
This study aims to see if a different way of giving the tuberculosis (TB) vaccine makes it work better. Researchers are comparing the standard skin injection to a new method where the vaccine is inhaled as a mist. They are also checking if people with Type 2 diabetes have a different immune response to the vaccine booster than people without diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre for Clinical Vaccinology and Tropical Medicine
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.